WuXi AppTec (English); 药明康德（中文）
Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process. Our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.
Ge Li, Ph.D., Chairman and CEO
Our vision is to become the most comprehensive capability and technology platform in the global pharmaceutical and healthcare industry to fulfill the dream of “every drug can be made and every disease can be treated”.
Integrated R&D Platform
Small Molecule R&D and Manufacturing Platform
Biologics R&D and Manufacturing Platform
Cell & Gene Therapy R&D and Manufacturing Platform
Medical Device Testing Platform
Molecular Testing and Genomics Platform
Estimated $800M USD in 2015
Number of Customers
>2,000 customers globally
5.5 million square feet in China and the United States, including facilities under construction
St. Paul, MN
San Diego, CA
Fields with * are required.